🔗 Share this article

The top legal official in Texas Ken Paxton is suing the manufacturers of Tylenol, asserting the firms withheld potential risks that the pain reliever presented to children's brain development.

The court filing comes a month after President Donald Trump publicized an unproven link between taking Tylenol - also known as acetaminophen - during pregnancy and autism spectrum disorder in young ones.

The attorney general is suing J&J, which once produced the drug, the only pain reliever recommended for pregnant women, and Kenvue, which now manufacturers it.

In a official comment, he claimed they "misled consumers by profiting off of suffering and promoting medication regardless of the potential hazards."

The manufacturer asserts there is lacking scientific proof linking Tylenol to autism spectrum disorder.

"These manufacturers deceived for years, intentionally threatening numerous people to increase profits," Paxton, a Republican, declared.

Kenvue commented that it was "seriously troubled by the perpetuation of misinformation on the security of acetaminophen and the possible consequences that could have on the well-being of American women and children."

On its official site, the company also said it had "consistently assessed the applicable studies and there is no credible data that shows a verified association between consuming acetaminophen and autism."

Organizations acting on behalf of medical professionals and health professionals share this view.

ACOG has said acetaminophen - the primary component in Tylenol - is a restricted selection for expectant mothers to address discomfort and elevated temperature, which can create major wellness concerns if not addressed.

"In over twenty years of investigation on the utilization of paracetamol in pregnancy, no reliable research has successfully concluded that the consumption of paracetamol in any trimester of gestation results in brain development issues in children," the association commented.

This legal action mentions current declarations from the previous government in claiming the medication is allegedly unsafe.

Last month, Trump raised alarms from medical authorities when he instructed pregnant women to "fight like hell" not to consume Tylenol when unwell.

The FDA then issued a notice that physicians should think about restricting the consumption of acetaminophen, while also mentioning that "a proven link" between the medication and autism in young ones has not been established.

Health Secretary Robert F Kennedy Jr, who oversees the FDA, had promised in April to initiate "comprehensive study program" that would establish the source of autism spectrum disorder in a short period.

But specialists cautioned that identifying a unique factor of autism - considered by experts to be the consequence of a intricate combination of genetic and environmental factors - would prove challenging.

Autism spectrum disorder is a type of enduring cognitive variation and impairment that affects how individuals encounter and interact with the world, and is diagnosed using physician assessments.

In his lawsuit, the attorney general - a Trump ally who is seeking the Senate - alleges the manufacturer and Johnson & Johnson "intentionally overlooked and tried to quiet the evidence" around acetaminophen and autism spectrum disorder.

The case seeks to make the corporations "eliminate any commercial messaging" that states acetaminophen is safe for expectant mothers.

This legal action mirrors the concerns of a group of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in 2022.

A federal judge rejected the legal action, saying research from the plaintiffs' authorities was inconclusive.